Whalesbook
Zydus Lifesciences is planning a Qualified Institutional Placement (QIP) to raise up to Rs 5,000 crore. The company has appointed Jefferies, JP Morgan, and IIFL Capital as advisors for this capital raise, expected by late December or early 2026. The funds will be utilized to reduce existing debt and support mergers and acquisitions (M&A), particularly to strengthen its US specialty business and explore innovative assets.